Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PLG | P00747 | 1/20 | 0.46 |
| ▸ | PLAT | P00750 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961978 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL4159836 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL4159828 | 1.00 | PKM (0.51) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27748051 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27480731 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27480730 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9746896 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9578611 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL9578607 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A | |
| SCHEMBL27748100 | 0.98 | TP53 (0.54) | PKMTP53HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112034644-A | Gel-stabilized liquid crystal writing board film and preparation method thereof | 南京优写智能科技有限公司 | 2020-12-04 | — | — | CN | claimed |
| EP-0285617-B1 | LIQUID CRYSTAL PHASE | MERCK PATENT GmbH (DE) | 1991-12-27 | — | — | EP | claimed |
| EP-4720035-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4634327-A1 | COMPOSITION FOR FORMING A LIQUID CRYSTAL ALIGNMENT FILM | Rolic Technologies AG (CH) | 2025-10-22 | — | — | EP | disclosed |
| US-20250180952-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2025-06-05 | — | — | US | disclosed |
| EP-4528369-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | Nissan Chemical Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| US-12234402-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2025-02-25 | — | — | US | disclosed |
| EP-4493638-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2025-01-22 | — | — | EP | disclosed |
| US-20250000797-A1 | NANOMATERIALS | GUIDE THERAPEUTICS, LLC | 2025-01-02 | — | — | US | disclosed |
| US-12162834-B2 | Reactive mesogens | MERCK PATENT GMBH (DE) | 2024-12-10 | — | — | US | disclosed |
| WO-2024249525-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-0418362-B1 | TRIFLUOROMETHYLCYCLOHEXANE DERIVATIVES | MERCK PATENT GMBH (DE) | 1995-01-04 | — | — | EP | disclosed |
| US-5348677-A | Electro-optical liquid crystal display element | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1994-09-20 | — | — | US | disclosed |
| US-5279764-A | Dihalogenobenzene derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1994-01-18 | — | — | US | disclosed |
| US-5209868-A | Liquid crystal medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-05-11 | — | — | US | disclosed |
| US-5196140-A | ELECTRO-OPTICAL LIQUID CRYSTAL DISPLAY ELEMENT | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-03-23 | — | — | US | disclosed |
| EP-0393636-A2 | Liquid crystal composition and liquid crystal display using said composition | CHISSO CORPORATION (JP) | 1990-10-24 | — | — | EP | disclosed |
| US-4617140-A | Bicyclohexyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| US-4526704-A | Esters containing phenylene and cyclohexylene rings | HOFFMANN-LA ROCHE INC. (US) | 1985-07-02 | — | — | US | disclosed |
| US-4181625-A | CARBONITRILES, DIELECTRICS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000797-A1 | NANOMATERIALS | POLRMT, PHOSPHO1, FABP1 | PKM 2665/4885TP53 1184/4885HTT 916/4885 |
| US-12162834-B2 | Reactive mesogens | BLM, MAS1, MCHR1 | PKM 3805/4885TP53 3583/4885HTT 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.